Theraclion SA (EPA:ALTHE)
France · Delayed Price · Currency is EUR 0.6600
-0.1100 (-14.29%)
At close: Jan 30, 2026
Theraclion Revenue
Theraclion had revenue of 944.00K EUR in the half year ending June 30, 2025, a decrease of -3.77%. This brings the company's revenue in the last twelve months to 1.87M, up 210.90% year-over-year. In the year 2024, Theraclion had annual revenue of 830.21K, down -54.44%.
Revenue (ttm)
1.87M
Revenue Growth
+210.90%
P/S Ratio
16.55
Revenue / Employee
58.57K
Employees
31
Market Cap
31.01M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 830.21K | -992.01K | -54.44% |
| Dec 31, 2023 | 1.82M | 586.77K | 47.49% |
| Dec 31, 2022 | 1.24M | -245.50K | -16.58% |
| Dec 31, 2021 | 1.48M | 736.95K | 99.05% |
| Dec 31, 2020 | 744.00K | -2.39M | -76.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Guerbet | 820.92M |
| Biosynex | 97.95M |
| Diagnostic Medical Systems | 49.47M |
| Median Technologies | 23.38M |
| Novacyt | 22.69M |
| Bluelinea Société Anonyme | 11.68M |
| Implanet | 11.10M |
| Mauna Kea Technologies | 8.18M |